Business
Conference Participation in March & April 2025
Conference Participation in March & April 2025.
About this update from Poolbeg Pharma Plc
[{"type":"text","content":"\n\nPoolbeg Pharma plc\n \nPoolbeg to Participate in Key Conferences in March and April 2025\n \nPoolbeg to present at Master Investor Show, BioTrinity & Participate in a Panel Discussion at LSX World Congress\n \n27 March 2025 - Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that CEO, Jeremy Skillington, will be participating in the following leading industry conferences in March and April 2025:\nMaster Investor Show - Business Design Centre, London, UK\nPresentation details: 29 March, Showcase Stage (Ground Floor), 1.00pm - 1.10pm\nPoolbeg Pharma will be located at Booth M30.\n \nBioTrinity - Convene, 133 Houndsditch, London, UK\nPresentation details: 2 April, Science Spotlight 8 - Rare Disease, 9.30am - 11am\nPoolbeg Pharma's presentation will focus on its drug candidate POLB 001, an oral preventative therapy for cancer immunotherapy-induced CRS.\n \nLSX World Congress - Business Design Centre, London, UK\nPanel title: \"Thriving Amidst Turbulence: Building Resilience in Life Sciences\"\nPanel date & time: 30 April, 2pm\n \nIf you would like to meet the Poolbeg team at any of the above events, please contact us at [email protected].\n \nEnquiries \n \n\n\n\n\nPoolbeg Pharma Plc \nJeremy Skillington, CEO \nIan O'Connell, CFO \n \n\n\n+44 (0) 207 183 1499\[email protected]\n\n\n\n\nCavendish Capital Markets Ltd (NOMAD & Joint Broker) \nGeoff Nash, Camilla Hume, Trisyia Jamaludin (Corporate Finance)\nNigel Birks (Life Science Specialist Sales)\nHarriet Ward (ECM) \n \n\n\n+44 (0) 207 220 0500 \n\n\n\n\nShore Capital Stockbrokers Ltd (Joint Broker)\nDavid Coaten, Harry Davies-Ball (Corporate Advisory)\nMalachy McEntyre, Isobel Jones (Corporate Broking)\n \n\n\n+44 (0) 207 408 4090\n\n\n\n\nJ&E Davy (Joint Broker) \nAnthony Farrell, Niall Gilchrist\n \n\n\n+353 (0) 1 679 6363 \n\n\n\n\nOptimum Strategic Communications \nNick Bastin, Vici Rabbetts, Elena Bates \n \n\n\n+44 (0) 208 078 4357 \[email protected] \n\n\n\n\nAbout Poolbeg Pharma plc \nPoolbeg Pharma plc is a clinical-stage biopharmaceuti...